Zobrazeno 1 - 10
of 105
pro vyhledávání: '"L. Wingerup"'
Autor:
Per L. Wingerup, Steven E. Gross
Publikováno v:
Compensation & Benefits Review. 31:25-34
Business executives around the world agree that attracting, retaining and motivating employees globally is a key business objective in the 21st century. Organizations that can provide mean-ingful motivational rewards to employees across cultures stan
Publikováno v:
Forman, A, Ulmsten, U, Bányai, J, Wingerup, L & Uldbjerg, N 1982, ' Evidence for a local effect of intracervical prostaglandin E2-gel ', American Journal of Obstetrics and Gynecology, vol. 143, no. 7, pp. 756-60 .
Aarhus University
Aarhus University
Udgivelsesdato: 1982-Aug-1 Eight primigravid women with a mean gestational age of 9.4 weeks (9 to 10 weeks) who were admitted for first-trimester abortion by dilatation and evacuation were preoperatively treated for 6 hours with either intravenous in
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 62:163-166
A survey of connective tissue in general and human cervical connective in particular is presented. It is concluded that about 90% of the human cervix consists of fibrous connective tissue which, according to the composition of the collagen and the pr
Publikováno v:
Clinical Obstetrics and Gynecology. 26:95-105
Autor:
K.E. Andersson, A. Robichaud, S. Kunz, U. Ulmsten, Walther Kuhn, W.Y. Ling, H. Becker, L. Martini, P. Limota, M. Perez-Gil, M. Fenske, Mac Leod, J. Bischoff, Paul Morf, H. Prestele, E. Tölle, G. Grospietsch, G. Gavazzi, B.K. van Kreel, I. Zayid, W. Wrixon, Henk C.S. Wallenburg, F. Piva, L. Wingerup, J. Borell, J. Girndt, R.C. Briel, A. Pellicer, F. Bonilla-Musoles, E.-M. Rebhan, A. Drähne
Publikováno v:
Gynäkologisch-geburtshilfliche Rundschau. 20:I-IX
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 62:131-136
The methods used to date to ripen the unfavorable cervix during pregnancy have considerable disadvantages, chiefly from the practical point of view. Intracervical application of a small dose (0.5 mg) of prostaglandin E2 (PGE2) in viscous gel is a saf
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 58:15-18
In a randomized double-blind study a viscous gel, containing 0.25 mg prostaglandin E2 (PGE2-gel) or without prostaglandin (placebo gel), was applied intracervically in twenty-two nulliparous patients just before termination of early pregnancy by dila
Autor:
R.C. Briel, A. Pellicer, L. Martini, E.-M. Rebhan, J. Borell, A. Drähne, H. Becker, E. Tölle, G. Gavazzi, P. Limota, K.E. Andersson, W. Wrixon, S. Kunz, Henk C.S. Wallenburg, J. Bischoff, H. Prestele, G. Grospietsch, M. Fenske, Paul Morf, J. Girndt, Walther Kuhn, W.Y. Ling, Mac Leod, A. Robichaud, U. Ulmsten, F. Bonilla-Musoles, M. Perez-Gil, F. Piva, B.K. van Kreel, I. Zayid, L. Wingerup
Publikováno v:
Gynäkologisch-geburtshilfliche Rundschau. 20:247-255
Publikováno v:
Archives of Gynecology. 234:61-65
Fifty-four women with an unripe cervix at term were given 0.5 mg intracervical prostaglandin E2 (PGE2) gel. In 37 of them (70%) the cervix ripened within 5 h and seven of them were in labor at that time. Of the remaining 30 patients, 15 were randomly
Publikováno v:
Gynecologic and Obstetric Investigation. 15:291-299
Intracervical application of prostaglandin E2 in the late first trimester induces (1) softening of the cervix tissue; (2) increase in sulfated glycosaminoglycans (18 ± 12%, mean ±